Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Randomized Open-Label Study on the Efficacy and Safety of Intermittent Preventive Treatment in Pregnancy (IPTp) With Dihydroartemisinin-Piperaquine (DP) Versus IPTp With Sulfadoxine-Pyrimethamine (SP) in Malawi

NCT03009526 is registered in ClinicalTrials.gov with Kamuzu University of Health Sciences as lead sponsor.

NCT NCT03009526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03009526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Randomized Open-Label Study on the Efficacy and Safety of Intermittent Preventive Treatment in Pregnancy (IPTp) With Dihydroartemisinin-Piperaquine (DP) Versus IPTp With Sulfadoxine-Pyrimethamine (SP) in Malawi
Lead sponsor
Kamuzu University of Health Sciences
Phase
Phase 3
Overall status
Completed
Start date
January 17, 2017
Completion date
October 24, 2018
Enrollment
602 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria, pregnancy